
Molecular Medicine, Год журнала: 2024, Номер 30(1)
Опубликована: Дек. 20, 2024
Язык: Английский
Molecular Medicine, Год журнала: 2024, Номер 30(1)
Опубликована: Дек. 20, 2024
Язык: Английский
Critical Reviews in Oncology/Hematology, Год журнала: 2023, Номер 185, С. 103961 - 103961
Опубликована: Март 13, 2023
Язык: Английский
Процитировано
52Pharmaceuticals, Год журнала: 2024, Номер 17(8), С. 1048 - 1048
Опубликована: Авг. 9, 2024
The establishment and utilization of preclinical animal models constitute a pivotal aspect across all facets cancer research, indispensably contributing to the comprehension disease initiation progression mechanisms, as well facilitating development innovative anti-cancer therapeutic approaches. These have emerged crucial bridges between basic clinical offering multifaceted support investigations. This study initially focuses on importance benefits establishing models, discussing different types recent advancements in research. It then delves into treatment, studying characteristics stages tumor drugs. By integrating hallmarks we elaborate path drug provide guidance personalized therapy strategies, including synthetic lethality approaches novel drugs widely adopted field. Ultimately, summarize strategic framework for selecting safety experiments, tailored experimental modalities species, present an outlook prospects challenges associated with models. undoubtedly offer new avenues encompassing protocols. Nevertheless, road ahead continues be lengthy fraught obstacles. Hence, encourage researchers persist harnessing advanced technologies refine thereby empowering these emerging paradigms positively impact patient outcomes.
Язык: Английский
Процитировано
4Hepatobiliary & pancreatic diseases international, Год журнала: 2024, Номер 23(6), С. 628 - 637
Опубликована: Июнь 4, 2024
Язык: Английский
Процитировано
2Molecular Medicine, Год журнала: 2024, Номер 30(1)
Опубликована: Дек. 20, 2024
Язык: Английский
Процитировано
0